chr6-16141654-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013262.4(MYLIP):c.308C>A(p.Ala103Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000279 in 1,613,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A103V) has been classified as Likely benign.
Frequency
Consequence
NM_013262.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYLIP | NM_013262.4 | c.308C>A | p.Ala103Asp | missense_variant | 3/7 | ENST00000356840.8 | NP_037394.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLIP | ENST00000356840.8 | c.308C>A | p.Ala103Asp | missense_variant | 3/7 | 1 | NM_013262.4 | ENSP00000349298.3 | ||
MYLIP | ENST00000349606.4 | c.-236C>A | 5_prime_UTR_variant | 2/6 | 1 | ENSP00000008686.6 | ||||
MIR4639 | ENST00000584938.1 | n.*30C>A | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250782Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135538
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461164Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 20AN XY: 726898
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with MYLIP-related conditions. This variant is present in population databases (rs752715251, gnomAD 0.006%). This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 103 of the MYLIP protein (p.Ala103Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at